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OBJECTIVES We sought to investigate the role of cardiotropic viruses, including adenovirus, cytomegalo-
virus (CMV), enterovirus and parvovirus, in arrhythmogenic right ventricular dysplasia/
cardiomyopathy (ARVD/C).
BACKGROUND Arrhythmogenic right ventricular dysplasia/cardiomyopathy is characterized by a gradual loss
of myocytes, inflammatory infiltrates and replacement by fatty and fibrous tissue. It has been
speculated that ARVD/C is a sequela of viral myocarditis in some patients, and the role of the
coxsackievirus B3 has been debated.
METHODS Myocardial samples from 12 patients with ARVD/C were analyzed by polymerase chain
reaction for the presence of cardiotropic viruses.
RESULTS Enteroviral sequences were detected in seven patients and adenovirus type 5 in another two
patients. During the same period, 215 control samples were analyzed in which only CMV
(n  2) and enterovirus (n  1) were detected. This suggests a link between ARVD/C and
the presence of viral genome (enterovirus or adenovirus) in the myocardium.
CONCLUSIONS We report that cardiotropic viruses are more frequently identified in patients with ARVD/C
than in control subjects. However, the role of these viruses in ARVD/C pathogenesis remains
unknown. (J Am Coll Cardiol 2002;39:892–5) © 2002 by the American College of
Cardiology Foundation
Arrhythmogenic right ventricular dysplasia/cardiomyopathy
(ARVD/C) is a complex arrhythmogenic disorder associ-
ated with cardiomyopathy and characterized by a gradual
loss of myocytes and replacement by fatty and fibrous tissue
(1). It leads to dilation of the right ventricle (RV) and
impaired cardiac function. The clinical course is character-
ized by ventricular arrhythmias (ventricular tachycardia), heart
failure, syncope and sudden death. In Italy, the prevalence has
been reported to be 1 in 5,000 people, accounting for 20% of
sudden deaths in young adults (2) and 25% of sudden cardiac
deaths among athletes (3). However, the incidence and prev-
alence are unknown in the U.S. Goodin et al. (4) reported a
frequency at autopsy of 0.55% among young adults with
sudden cardiac death in Maryland.
ARVD/C was first reported as the partial replacement of
the RV myocardium by fat or fibrous tissue. In 1965, Dalla
Volta et al. (5) described the disease as “auricularization of
the RV curve due to loss of the contractile power of the
RV.” Later, Frank et al. (6) referred to this new entity as RV
dysplasia, and Fontaine et al. (7) added the term “arrhyth-
mogenic.” In 1996, ARVD/C was added to the World
Health Organization classification of cardiomyopathies (8).
In familial cases of ARVD/C, autosomal-dominant in-
heritance with reduced penetrance has been reported and
accounts for 30% of cases. In the remaining sporadic
cases, it is believed to be due to an acquired etiology or to
unidentified inheritance. The first gene for autosomal-
dominant ARVD/C was recently identified, encoding the
cardiac ryanodine receptor 2 on chromosome 1q42-43 (9).
In addition, two genes responsible for Naxos disease, a
complex autosomal-recessive form of ARVD/C with asso-
ciated palmoplantar keratoderma and woolly hair, have been
identified as plakoglobin and desmoplakin—important pro-
teins in the cardiac adherens junctions (10,11).
The role of infectious agents in sporadic cases of
ARVD/C has been proposed because of the common
finding of inflammatory infiltrates in the myocardium
(1,12), suggesting that ARVD/C is a sequela of myocarditis
(like dilated cardiomyopathy [DCM]). Therefore, viruses
associated with myocarditis have been proposed as po-
tential etiologic agents. In 1998, Grumbach et al. (13)
reported the detection of coxsackievirus B3 in the myo-
cardium of 3 of 8 patients with ARVD/C, although
Calabrese et al. (14) did not detect enteroviral ribonucleic
acid (RNA) in any of 20 patient samples analyzed. Thus,
the role of enteroviruses has remained controversial, and
the involvement of other cardiotropic viruses (including
adenovirus, cytomegalovirus [CMV] and parvovirus) has
not been reported. Here we describe the detection of
viruses (enterovirus or adenovirus) in 7 of 12 patients
with sporadic ARVD/C.
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METHODS
Clinical diagnostic criteria for ARVD/C. All human
studies were performed in accordance with local Institu-
tional Review Board regulations. Diagnostic criteria were
those according to McKenna et al. (15). All patients were
required to have clinical ventricular tachycardia (VT) with a
left bundle branch block pattern, echocardiographic evi-
dence of RV dilation, with or without evidence of RV
thinning and/or outflow tract dilation by echocardiography
or magnetic resonance imaging, and histopathologic evi-
dence of RV fibrofatty infiltration. All patients were evalu-
ated by electrocardiography, Holter monitoring, echocardi-
ography, magnetic resonance imaging and either
endomyocardial biopsy, autopsy or explant histologic anal-
ysis. Biopsy samples were obtained only in patients in whom
the clinical diagnosis was uncertain. A family history was
obtained for all patients, and pedigrees were constructed.
Nuclear family members (i.e., parents and siblings) were
clinically evaluated for evidence of ARVD/C, using identi-
cal criteria. Any other family members (e.g., grandparents,
aunts, uncles, cousins) considered at risk due to a medical
history were also fully evaluated noninvasively. Control
samples were obtained at the time of explantation for
patients undergoing transplantation for end-stage congeni-
tal heart disease, or autopsy in trauma victims, and for those
dying suddenly due to hypertrophic cardiomyopathy.
After cardiac catheterization and endomyocardial biopsy,
the biopsy specimens were snap-frozen in liquid nitrogen or
formalin-fixed for polymerase chain reaction (PCR) analy-
sis. All explanted hearts were sampled (RV and left ventricle
[LV]) and snap-frozen within 10 min of explantation. All
autopsies were performed in standard fashion; LV and RV
wedges were frozen, formalin-fixed or paraffin-embedded.
In all cases, histologic analysis included hematoxylin-eosin,
Masson trichrome and period acid-Schiff staining. Histo-
logic results were based on the McKenna criteria for
ARVD/C (15) and the Dallas criteria for myocarditis (16).
Patient samples and PCR analysis. Total RNA and
deoxyribonucleic acid (DNA) were isolated simultaneously
from tissue samples, as previously described (17–19). For
detection of the enteroviruses, RSV and influenza viruses
(i.e., RNA viruses), reverse transcriptase-PCR was em-
ployed, whereas for adenoviruses, CMV, herpes simplex
virus (HSV), parvovirus and Ebstein-Barr virus (EBV) (i.e.,
DNA viruses), PCR was utilized (17–19). Primers were
designed to the 5 untranslated region of the enteroviruses,
the hexon gene of the adenoviruses, the phosphoprotein 120
gene of CMV, DNA polymerase of HSV (types 1 and 2),
the EcoR I fragment of EBV, the VP1 gene of parvovirus
B19, the nonstructural protein region of influenza A and the
F-glycoprotein of RSV (17–19). For all analyses, negative
and positive control reactions were performed in an identical
manner to the test reactions, using water and viral nucleic
acid, respectively, as the template.
All samples were analyzed without knowledge of the
clinical, culture or serologic data and were performed in
duplicate. Verification of the presence of amplifiable nucleic
acid extracted from each sample was performed by ampli-
fication of cellular nucleic acid (K-ras or beta-actin).
Statistical analysis. Frequencies of virus detection between
the ARVD/C group and the control group were compared
using chi-square analysis.
RESULTS
During the seven-year period (1993 to 2000), samples from
1,000 individuals were evaluated by viral PCR, including 12
with ARVD/C (mean age 19 years; range 16 to 23 years)
and 215 control subjects. Of the control subjects, 123 had
congenital heart disease (mean age 14 years; range 3 months
to 31 years), 42 had hypertrophic cardiomyopathy (mean
age 21 years; range 3 to 29 years) and 50 were trauma
victims (mean age 20 years; range 13 to 30 years). None of
the control subjects had a history of recent viral illness or
histologic evidence of myocarditis.
All cases of ARVD/C were considered sporadic based on
pedigree analysis, indicating no other affected individuals or
sudden deaths in the extended family by history and
noninvasive testing. Clinical screening of family members of
all patients was negative for evidence of ARVD/C. No
patient had previous episodes of flu-like or other viral
illnesses in the three months before diagnosis.
Of the 12 ARVD/C patient samples, viruses were de-
tected in 7 (58%) (Table 1). Of these seven patients,
enteroviruses were detected in five patients and adenovirus
type 5 in two patient (Fig. 1 and Table 1). In contrast, only
Abbreviations and Acronyms
ARVD/C  arrhythmogenic right ventricular dysplasia/
cardiomyopathy
CMV  cytomegalovirus
DCM  dilated cardiomyopathy
DNA  deoxyribonucleic acid
EBV  Epstein-Barr virus
HSV  herpes simplex virus
LV  left ventricle or ventricular
PCR  polymerase chain reaction
RNA  ribonucleic acid
RV  right ventricle or ventricular
VT  ventricular tachycardia
Table 1. Results of PCR: Viral Genome Amplified
Diagnosis
Sample
No.
Viral
PCR
VE (n)
PCR
Amplimer
(No. Positive)
Samples
(%)
Patients with ARVD/C 12 7 Enterovirus (5) 42
Adenovirus (2) 17
Control subjects 215 3 CMV (2) 1
Enterovirus (1) 1
ARVD/C  arrhythmogenic right ventricular dysplasia/cardiomyopathy; CMV 
cytomegalovirus; PCR  polymerase chain reaction.
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three (2%) of the control subject samples were virus-
positive: CMV in two and enterovirus in one (Table 1),
indicating a significantly increased frequency of virus iden-
tification in patients with ARVD/C as compared with
control subjects (p  0.01). The 12 patients with ARVD/C
were diagnosed in 11 different centers in the U.S.: analysis
of their demographic data showed that the control group
included individuals matched with the ARVD/C group for
age, gender, race, ethnicity and geographic region.
A comparison of the histologic findings of myocardial
samples, as well as the clinical characteristics at clinical
presentation, did not distinguish patients positive for either
enterovirus or adenovirus (Table 2) from those negative for
viral genome.
All of the patients with ARVD/C presented with syncope
or VT, or both, except for one young man (R. P.) (Table 2)
who presented with heart failure. The primary presentation
of syncope and VT is an uncommon event in pediatric
patients, and in many centers, these individuals undergo
electrophysiologic testing and endomyocardial biopsy dur-
ing the diagnostic evaluation, unless an etiologic diagnosis
(such as long QT syndrome or Brugada syndrome) is made
by noninvasive testing. In addition, the noninvasive evalu-
ation of ARVD/C is commonly nondiagnostic, leading to
invasive evaluation. Hence, in all patients presenting with
syncope or VT, biopsies were obtained (n  6) at five
different medical centers. Of the remaining patients, three
underwent transplantation and three underwent autopsy
after sudden death.
DISCUSSION
Detection of viruses in the myocardium. Here we report
the detection of virus sequences in myocardial samples of
patients with sporadic ARVD/C. The viruses detected are
the same as those identified in the myocardium of patients
with myocarditis or DCM, supporting the hypothesis that
ARVD/C is a sequela of viral myocarditis in some patients.
Sequence analysis was not performed on the enterovirus-
positive samples, but in patients with myocarditis or DCM,
coxsackievirus B3 is the most commonly detected enterovi-
rus, and Grumbach et al. (13) reported the detection of
coxsackievirus B3 in patients with ARVD/C. In both
patients in whom adenovirus was detected, the virus was
serotyped by DNA sequencing as adenovirus type 5, a group
C adenovirus commonly detected in patients with myocar-
ditis or DCM (19).
The role of viruses in ARVD/C pathogenesis. The cause
and effect association between the detection of virus and the
etiology of myocarditis and DCM has been widely accepted.
In a recent study of heart transplant patients undergoing
routine follow-up for rejection, we reported a significant
association between the detection of virus in the myocar-
dium and the onset of disease (20). However, it is not clear
whether the detection of viruses in patients with ARVD/C
represents a cause and effect relationship. The similarities
between ARVD/C and myocarditis/DCM in terms of
histopathologic findings and ventricular dilation could sup-
port an etiologic role for these viruses. However, the distinct
pathologic differences between ARVD/C and myocarditis/
Figure 1. The detection of adenoviral deoxyribonucleic acid (DNA) in
arrhythmogenic right ventricular dysplasia/cardiomyopathy patient sam-
ples. Lane M  100 base pair (bp) DNA ladder; RP  patient R.P.;
AM  patient A.M.;   negative control (water); AD2  adenovirus
type 2 positive control DNA.
Table 2. Characteristics of the Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Who Were Positive
for Virus
Patient
Initials
Age of
Onset (yrs)
Gender
Origin of
Sample
PCR
Result
PCR
Date Pathology
Clinical
Presentation Disease Duration
Clinical
Outcome
F. P. 16/M RV biopsy Enterovirus 4/93 Fibrofatty infiltration of
RV
Syncope, VT 26 mo ICD
R. P. 22/M RV, LV explant Adenovirus 5/93 Fibrofatty infiltration of
RV, lymphocytes
CHF, biventricular
failure
16 mo Transplant
M. G. 17/F RV biopsy Enterovirus 6/94 Fibrofatty infiltration of
RV, lymphocytes
Syncope 3 yrs Stable
C. B. 23/M RV, LV explant Enterovirus 11/94 Fibrofatty infiltration of
RV/LV
Polymorphic VT 2 yrs ICD, transplant
D. P. 19/F RV, LV autopsy Enterovirus 1/95 Fibrofatty infiltration of
RV
Syncope, SCD Autopsy diagnosis SCD
J. L. 19/F RV biopsy Enterovirus 4/96 Fibrofatty infiltration of
RV, lymphocytes
VT 30 mo ICD
A. M. 16/M RV biopsy Adenovirus 10/99 Fibrofatty infiltration of
RV/LV
Syncope, VT 6 mo ICD
CHF  congestive heart failure; ICD  implantable cardioverter defibrillator; LV  left ventricle; PCR  polymerase chain reaction; RV  right ventricle; SCD  sudden
cardiac death; VT  ventricular tachycardia.
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DCM, with respect to fatty infiltrates, primary RV disease
versus LV disease, as well as the high frequency of ventric-
ular arrhythmias, suggest that in patients with ARVD/C,
other pathologic processes are occurring, which could argu-
ably result in increased susceptibility to infection with
cardiotropic viruses. In this case, the detection of viruses
may simply represent a marker of the pathologic changes
occurring in the myocardium. Interestingly, Diong and
Knowlton (21) recently reported that dystrophin-deficient
mice, which have increased disruption of the sarcolemma,
are more susceptible to enterovirus infection of the myocar-
dium and the development of virus-induced cardiomyopa-
thy, suggesting these two hypotheses are not mutually
exclusive.
Assuming an etiologic role for these viruses, rather than
being a marker of disease, it is possible that infection of the
myocardium results in activation of inflammatory mediators
and adipose deposition cascades that ultimately disrupt the
cardiac adherens junctions and the T-tubule system. These
changes could secondarily cause ventricular irritability or ion
channel disruption, or both (e.g., through ryanodine recep-
tor changes), resulting in the signs and symptoms of
ARVD/C.
Conclusions. Cardiotropic viruses (e.g., enterovirus and
adenovirus) are identified more frequently in patients with
ARVD/C than in control subjects. However, the role of
these viruses in disease pathogenesis remains unknown,
particularly whether these viruses contribute to disease or
whether the diseased myocardium is more prone to virus
infection.
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